Get startedLog in
    Picture of Pacira Biosciences logo

    PCRX — Pacira Biosciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapSuper Stock
    All News

    Brief: Pacira Biosciences, Announces Pricing Of $250.0 Million Aggregate Principal Amount Of 2.125% Convertible Senior Notes Due 2029

    Picture of Pacira Biosciences logoPacira Biosciences
    10/05/2024 12:07
    May 10 (Reuters) - Pacira Biosciences Inc  PCRX.O :
    * PACIRA BIOSCIENCES, INC. ANNOUNCES PRICING OF $250.0
MILLION
AGGREGATE PRINCIPAL AMOUNT OF 2.125% CONVERTIBLE SENIOR NOTES
DUE 2029
    * PACIRA CONVERTIBLE SENIOR NOTES MATURITY SET FOR MAY 15,
2029

Source text for Eikon:  ID:nGNX5GH1D0 
Further company coverage:  PCRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Pacira Biosciences

    See all news